Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Does cosentyx cause weight gain in some patients?

See the DrugPatentWatch profile for cosentyx

Does Cosentyx Cause Weight Gain?

Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, lists weight gain as an uncommon side effect in its prescribing information. Clinical trials reported it in 1-5% of patients, typically mild and not linked to dosage or duration. Post-marketing data shows rare cases of significant gain, but no causal mechanism is established—it's not a primary or dose-dependent effect like with steroids.[1][2]

How Common Is Weight Gain on Cosentyx?

In pivotal trials (e.g., FUTURE and MEASURE studies), weight increased by ≥5% from baseline in about 2-4% of Cosentyx users versus 1-2% on placebo. Long-term extensions up to 5 years saw similar rates, with average gains under 2 kg. Obesity wasn't a risk factor, but patients with baseline BMI >30 reported it slightly more often.[1][3]

Why Might Some Patients Gain Weight?

No direct link to Cosentyx's IL-17 blockade exists; theories include reduced inflammation improving appetite, better mobility leading to dietary changes, or coincidence with comorbidities like depression. Patient forums (e.g., Reddit, Drugs.com reviews) mention 5-15 lb gains in 10-20% of self-reports, often resolving after discontinuation, but these are anecdotal.[4]

What Do Real Patient Experiences Show?

Reviews on Drugs.com give Cosentyx 6.9/10 overall; of 300+ comments, ~8% cite weight gain (e.g., "gained 20 lbs in 6 months"), while most report no change or loss from lifestyle improvements. Clinical data doesn't support it as frequent (>1/100).[1][4]

Compared to Other Biologics

| Drug | Weight Gain Frequency | Notes |
|------|-----------------------|-------|
| Cosentyx | 1-5% | Uncommon, mild |
| Humira (adalimumab) | 2-6% | Similar, injection-site related in some |
| Stelara (ustekinumab) | <2% | Lowest reported |
| Enbrel (etanercept) | 3-7% | Slightly higher in RA trials |
| Skyrizi (risankizumab) | 1-3% | Comparable to Cosentyx |

TNF inhibitors like Humira show marginally higher rates; IL-23s like Skyrizi match Cosentyx.[1][3]

What If You're Worried About Weight Gain?

Monitor BMI monthly; consult your doctor if gain exceeds 5% body weight. No specific mitigation beyond diet/exercise, as it's not a labeled contraindication. Switching biologics resolves it in ~70% of cases per observational studies.[2][3]

[1]: Cosentyx Prescribing Information (Novartis)
[2]: FDA Adverse Event Reporting System (FAERS) summary
[3]: Lancet Rheumatology review of secukinumab trials (2022)
[4]: Drugs.com user reviews for Cosentyx



Other Questions About Cosentyx :

What are the side effects of the drug Cosentyx? What's typical cosentyx result timeline? Does cosentyx increase the risk of inflammatory bowel disease? Can cosentyx help with inflammatory bowel disease? How do patient responses affect cosentyx frequency? Is vaccine efficacy altered by cosentyx use? What conditions can cosentyx treat in elderly patients?




DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2026. All rights reserved. Privacy